Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where C.G. Teo is active.

Publication


Featured researches published by C.G. Teo.


Journal of Clinical Virology | 2009

Genotyping of acute HBV isolates from England, 1997-2001

Richard D. Sloan; Angela L. Strang; Mary Ramsay; C.G. Teo

BACKGROUND Increasing data shows the relevance of HBV genotypes in the outcome of infection. Most studies investigating the relationship between the genotypic characteristics of hepatitis B virus (HBV) and the clinical or epidemiological aspects of HBV infection originate from studies of patients with chronic rather than acute hepatitis B. OBJECTIVES To study a convenience sample representing ca. 5% of reported acute hepatitis B in England between 1997 and 2001 to investigate the distribution of HBV genotypes and specific HBV variants with epidemiological risk factors, thereby providing baseline data for ongoing surveillance. STUDY DESIGN From 160 serum samples, PCR was carried out to amplify the first 600 bases of the HBV S gene. Amplicons were sequenced and subjected to phylogenetic analysis and risk factor analysis. RESULTS Fifty-seven percent of the study samples carried HBV belonging to subtype A2, 13% to subtype D2, and the rest to genotype E (8%) and subtypes C2 and D3 (each 6%), D1 and D4 (each 3%) and B4 (1%). One particular A2 isolate was dominant, accounting for 23% of the total sample set. Drug use and homosexual transmission were equally implicated as risks within genotype A2. No mutations associated with vaccine escape or resistance to antiviral therapy were identified. CONCLUSION Immigration and travel likely shape the observed genotype distribution and consequent prevalence of genotypes other than A2 or D in this population. Data suggests no genetic separation of parenteral and sexually transmitted virus. These data demonstrate the value in pursuing more extensive and recent surveillance.


Oral Microbiology and Immunology | 2009

Extensive oral shedding of human herpesvirus 8 in a renal allograft recipient

Lm Al-Otaibi; M. H. Al-Sulaiman; C.G. Teo; Stephen Porter

INTRODUCTION Studies were conducted to investigate changes in the extent of human herpesvirus 8 (HHV-8) shedding and diversity of HHV-8 strains in the mouth of a renal allograft recipient who developed cutaneous post-transplantation Kaposis sarcoma. METHODS Matched oral and blood samples were obtained from a Saudi Arabian renal allograft recipient from 3 days before to 38 weeks after transplantation, and from his kidney donor. Polymerase chain reaction (PCR) protocols to amplify selected HHV-8 sub-genomic regions were applied to detect and quantify HHV-8 DNA. Sequence diversity was determined by cloning the PCR products and subjecting them to denaturing gradient gel electrophoresis and to nucleotide sequencing. RESULTS Before transplantation, the recipient was seropositive for anti-HHV-8 immunoglobulin G, but the donor was seronegative; HHV-8 DNA could be detected in the recipients blood, whole-mouth saliva (WMS) and buccal exfoliates, and the salivary viral load was estimated as 2.6 million genome-copies/ml. Post-transplantation, the recipients salivary viral load initially increased to 4.1 million genome-copies/ml, and thereafter declined precipitously, coinciding with an increase in the dosage of valaciclovir given; HHV-8 DNA was detected most often in WMS compared with parotid saliva, and buccal and palatal exfoliates. Carriage of multiple HHV-8 strains was evident in blood and oral samples; whereas before transplantation strains belonging to genotypes A1 and A5 were observed, after transplantation genotype A5 strains became dominant and A2 strains emerged. CONCLUSION Immunosuppression and antiviral prophylaxis may interact to influence the spectrum of oral HHV-8 strains and the extent of post-transplantation HHV-8 shedding into the mouth.


Journal of Medical Virology | 2008

Outbreaks of Hepatitis A in England and Wales Associated With Two Co-Circulating Hepatitis A Virus Strains

Siew-Lin Ngui; Julia Granerod; Linda A. Jewes; N. S. Crowcroft; C.G. Teo

During 2002, an upsurge in frequency of hepatitis A outbreaks among injecting drug users was observed in England and Wales. As lack of risk factor information and the high mobility of the cases made linkage of outbreaks difficult, the relationship of nucleotide sequences in the VP1/2PA junction of the hepatitis A virus (HAV) genome amplified from serum of case‐patients was investigated. A total of 204 HAV RNA positive sera obtained from a network of 23 laboratories were studied. Comparison of the sequences identified two principal strains: ES1 (n = 95) belonging to type IB, and ES2 (n = 72) to type IIIA. Of the remaining samples, 15 were type IA, 11 were type IB and 11 were type IIIA. ES1 predominated in Doncaster and other towns in Trent and northern England, and ES2 in the Midlands and southern England; the difference in geographical distribution between these two strains was significant (P < 0.0001). In comparison to the sporadic cases, cases infected by either ES1 or ES2 tended to be younger, injecting drug users, people in contact with injecting drug users, or those with a history of incarceration in prisons or homelessness (P < 0.0001). Cases infected by ES1 tended to be younger than those by ES2 (P < 0.0001). The association of the outbreaks to two geographically restricted strains implicates two principal transmission pathways associated with injecting behavior. Identifying these routes may be conducive to preventing further outbreaks. J. Med. Virol. 80: 1181–1188, 2008.


Journal of Medical Virology | 2005

Anesthetist to patient transmission of hepatitis C virus associated with non exposure-prone procedures

J. Mawdsley; C.G. Teo; M. Kyi; M. Anderson

A 44‐year‐old lady was diagnosed with acute hepatitis C virus (HCV) infection 8 weeks after hysterectomy at which the attending anesthetist was known to be hepatitis C seropositive. Comparative nucleotide sequence analysis and phylogenetic comparison proved that transmission had occurred from the anesthetist to the patient. The patient had received general anesthesia with endotracheal intubation and peripheral intravenous cannulation. No exposure‐prone anesthetic procedures had been performed. This is the first case described in UK involving transmission from an anesthetist to a patient during anesthesia where no exposure prone procedures were carried out. It is the first example in which the anesthetist was known to be seropositive for hepatitis C prior to the operation. J. Med. Virol. 75:399–401, 2005.


Journal of Clinical Virology | 2005

Molecular epidemiology of hepatitis B in England and Wales.

C.G. Teo

This review focuses on general and molecular features of the epidemiology of incident and prevalent hepatitis B virus (HBV) infections in England and Wales. The situation in Scotland and Northern Ireland will not be reviewed.


Journal of Medical Virology | 2015

Hepatitis C virus genotype 4 in England: diversity and demographic associations

Siew-Lin Ngui; L. J. Brant; Peter V. Markov; John-Paul Tung; Oliver G. Pybus; C.G. Teo; Mary Ramsay

HCV strains belonging to genotype 4 may be gaining endemicity across Continental Europe but the extent of their spread in the United Kingdom is unknown. Sera referred from patients attending hospitals in England between 2004 through 2008 were characterised. A total of 243 sera carried HCV genotype 4. The most common subtypes were 4a (33%) and 4d (35%). Compared to patients infected by 4d, those infected by 4a were 20 times more likely to be Middle Eastern than English, and those infected by non‐4a/4d were older, tended to be female, and 50 or 12 times more likely to be Middle Eastern or South Asian, respectively, than English. Persons infected by 4d tended to be English rather than Middle Eastern or South Asian. One group of 4d strains clustered with strains reported from persons in Europe engaged in male homosexual activity. Surveillance of trends in the importation and subsequent spread of HCV genotype 4 and its subtypes is advocated. J. Med. Virol. 87:417–423, 2015.


Antiviral Therapy | 2008

Antiviral resistance mutations potentiate hepatitis B virus immune evasion through disruption of its surface antigen a determinant.

Richard D. Sloan; Samreen Ijaz; Moore Pl; Harrison Tj; C.G. Teo; Tedder Rs


Journal of Medical Virology | 2005

Inter‐ and intra‐person cytomegalovirus infection in Malawian families

Mohammed M. Beyari; T.A. Hodgson; W. Kondowe; E.M. Molyneux; Crispian Scully; Stephen Porter; C.G. Teo


Journal of Medical Virology | 2007

Salivary human herpesvirus 8 shedding in renal allograft recipients with Kaposi's sarcoma.

Lm Al-Otaibi; Siew-Lin Ngui; Crispian Scully; Stephen Porter; C.G. Teo


Journal of Medical Virology | 2008

Salivary human herpesvirus 8 shedding in renal allograft recipients with Kaposi's sarcoma (vol 79, pg 1357, 2007)

Lm Al-Otaibi; Siew-Lin Ngui; Crispian Scully; Porter; C.G. Teo

Collaboration


Dive into the C.G. Teo's collaboration.

Top Co-Authors

Avatar

Siew-Lin Ngui

Health Protection Agency

View shared research outputs
Top Co-Authors

Avatar

Crispian Scully

University College London

View shared research outputs
Top Co-Authors

Avatar

Lm Al-Otaibi

Health Protection Agency

View shared research outputs
Top Co-Authors

Avatar

Stephen Porter

UCL Eastman Dental Institute

View shared research outputs
Top Co-Authors

Avatar

A.J. Buckton

Health Protection Agency

View shared research outputs
Top Co-Authors

Avatar

Martin Fisher

Brighton and Sussex University Hospitals NHS Trust

View shared research outputs
Top Co-Authors

Avatar

Mary Ramsay

Health Protection Agency

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ranjababu Kulasegaram

Guy's and St Thomas' NHS Foundation Trust

View shared research outputs
Top Co-Authors

Avatar

Savita Rangarajan

Guy's and St Thomas' NHS Foundation Trust

View shared research outputs
Researchain Logo
Decentralizing Knowledge